Combination of two drugs that fight cardiovascular risk could also help treat the most common liver disease

Metabolic dysfunction-associated steatotic liver disease is the most common liver disease in the world, affecting about one-third of the adult population. This disorder is characterized by the accumulation of fat in liver cells, which has severe liver consequences and is also associated with a high mortality rate from cardiovascular disease.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup